Qualymed Pharma Private Limited
About Qualymed Pharma Private Limited
Data last updated:
Qualymed Pharma Private Limited is a private limited company based in Delhi, India. It was incorporated on 02 May 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U46497DL2023PTC413542. Its GSTIN is 05AAACQ8981B1ZG (Uttarakhand).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sahil Maheshwari and Sumeet Sood.
Its last annual general meeting (AGM) was held on 25 May 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 301 3rd Floor Laxmi Tower, Saraswati Vihar Lsc, Delhi, India – 110034.
As per the financials filed for FY 2026, the company reported a revenue of ₹5.36 Cr, a growth of 59% compared to the previous year. For the same year it recorded a net loss of ₹6.49 Cr (net margin -121.1%) and EBITDA of -₹1.26 Cr (EBITDA margin -23.5%).
Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending.
Company details
Contact details
Qualymed Pharma Private Limited's registered office is in Delhi, Delhi.
- Registered Address301 3rd Floor Laxmi Tower, Saraswati Vihar Lsc, Delhi, India – 110034
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Qualymed Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Qualymed Pharma Private Limited, buy the company report.
Financials of Qualymed Pharma Private Limited
FY 2025 filings availableQualymed Pharma Private Limited reported revenue of ₹5.36 Cr (up 59% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue rose 59% in the latest year. EBITDA fell 39% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹1.26 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹6.49 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -23.5% | ||
| Net Profit Margin | -121.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Qualymed Pharma Private Limited, buy the company report.
Board of directors of Qualymed Pharma Private Limited
Qualymed Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sahil Maheshwari | Director | 02 May 2023 | 3 Years 5 Months | Current |
| Sumeet Sood Also directs: Unosource Pharma Limited | Director | 02 May 2023 | 3 Years 5 Months | Current |
| Dinesh Kumar | Additional Director | 18 Jul 2025 | 1 Years 3 Months | Current |
Peer comparison
Qualymed Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Qualymed Pharma Private Limitedthis company | ₹5.36 Cr (FY 2026) | -₹6.49 Cr | -121.1% | 59.0% | Delhi, India | |
| Everlove Cosmetics & Beauty Care Private Limited | ₹3.39 Cr (FY 2025) | 249.0% | Mumbai, Maharashtra, India | |||
| RVG Earth & Minerals Private Limited | ₹3.39 Cr (FY 2024) | 37.0% | Delhi, India | |||
| Bisan Chemicals and Engineers Private Limited | ₹3.38 Cr (FY 2024) | 36.0% | Pune, Maharashtra, India | |||
| Strongard Paints Private Limited | ₹3.38 Cr (FY 2025) | 48.0% | Kalyan, Maharashtra, India | |||
| West Bengal Pharmaceutical & Phytochemical Development Corporation Ltd | ₹3.38 Cr (FY 2019) | -31.0% | Kolkata, West Bengal, India | |||
| Bio Trans Pharmaceuticals Private Limited | ₹3.37 Cr (FY 2024) | -8.0% | Athipattu, Tamil Nadu, India | |||
| Classic Aromatics Private Limited | ₹3.37 Cr (FY 2024) | -30.0% | New Delhi, Delhi, India | |||
| Edrok Formulation Private Limited | ₹3.37 Cr (FY 2025) | 55.0% | Aurangabad, Maharashtra, India | |||
| Unique Plant Care Private Limited | ₹3.37 Cr (FY 2025) | -8.0% | Delhi, India | |||
| Maskon Life Sciences Private Limited | ₹3.37 Cr (FY 2024) | 51.0% | Haridwar, Uttarakhand, India |
To see the full peer comparison of Qualymed Pharma Private Limited, buy the company report.
Legal cases
Qualymed Pharma Private Limited has 2 court cases on record: 2 filed by Qualymed Pharma. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Uttarakhand | Court case (WPMS) | Filed by the company against Regional Provident Fund Commissioner and 1 other | Pending |
| High Court of Uttarakhand | Court case (WPMS) | Filed by the company against Employees Provident Fund Organization | Disposed |
To see the full case history of Qualymed Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Qualymed Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Qualymed Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAACQ8981B1ZG | Uttarakhand | Active | 10 Aug 2023 |
To see the full GST registrations and return filing status of Qualymed Pharma Private Limited, buy the company report.
Recent activity
Qualymed Pharma Private Limited has 8 board changes on record since 2023: 7 appointments and 1 cessation. The latest: Dinesh Kumar was appointed as Additional Director on 18 Jul 2025.
Frequently asked questions
Qualymed Pharma is an active private limited company based in Delhi, India. It was incorporated on 02 May 2023 (3+ years old) and is registered under CIN U46497DL2023PTC413542.
Qualymed Pharma has 3 current directors:
- Sahil Maheshwari - Director
- Sumeet Sood - Director
- Dinesh Kumar - Additional Director
The latest financial statements of Qualymed Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 May 2025. Year-wise statements from FY 2024 are in the company report.
The GSTIN of Qualymed Pharma is 05AAACQ8981B1ZG, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Qualymed Pharma is U46497DL2023PTC413542. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Qualymed Pharma has 2 court cases on record: 2 filed by the company. 1 is pending.
Qualymed Pharma was incorporated on 02 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Qualymed Pharma by revenue are Everlove Cosmetics & Beauty Care Private Limited, RVG Earth & Minerals Private Limited, Bisan Chemicals and Engineers Private Limited, Strongard Paints Private Limited, West Bengal Pharmaceutical & Phytochemical Development Corporation Ltd and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dinesh Kumar was appointed as Additional Director on 18 Jul 2025. Subodh Gaur ceased to be Additional Director on 28 May 2024. Subodh Gaur was appointed as Director on 21 Nov 2023. Qualymed Pharma has 8 board changes on record in total.
The registered office of Qualymed Pharma is at 301 3rd Floor Laxmi Tower, Saraswati Vihar Lsc, Delhi, India – 110034.
Qualymed Pharma can be reached at its registered office: 301 3rd Floor Laxmi Tower, Saraswati Vihar Lsc, Delhi, India – 110034.